Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Peer Support Workers Study

29 de outubro de 2026 atualizado por: Jessica Moe, University of British Columbia

Creating Safety in Chaos: Integrating Peer Support Workers in Emergency Departments to Support Patients Who Use Substances and Opioids

Many people with high-risk opioid use visit emergency departments (EDs), facing a high risk of death if they leave before completing care. Peer support workers (Peers) - people with lived experience of substance use - may improve patient comfort, reduce early departures, and potentially lower mortality rates. This study aims to evaluate how a hospital-implemented ED Peer program can enhance patient support, reduce barriers to care, and provide harm-reduction resources in a person-centred and trauma-informed manner. The study will assess whether Peer availability and direct Peer-patient interactions are associated with improved ED care outcomes, including reduced leaving before treatment completion, as well as subsequent healthcare utilization, overdose, mortality, and other relevant patient outcomes.

Visão geral do estudo

Descrição detalhada

The study was initially designed as a feasibility evaluation of the ED Peer program and of the use of a randomized shift schedule to assign Peer availability. As program implementation progressed and staffing stabilized, the evaluation framework was refined to examine both the effect of Peer availability and outcomes associated with direct Peer-patient interaction.

From 23 November 2024 through 16 October 2025, Peer availability was assigned according to an a priori randomized shift schedule developed in collaboration with human resources and ED operational leadership. Following achievement of full Peer staffing, the program transitioned to routine clinical operation.

The study has two main analytic objectives: 1) during the shift-randomization period, investigators will compare outcomes between shifts with and without scheduled Peer availability among patients presenting with substance use-related concerns; 2) investigators will evaluate outcomes associated with direct Peer-patient interaction by comparing patients who interacted with a Peer with comparable patients who did not interact with a Peer.

The primary outcome is leaving before treatment completion (LBTC). Additional outcomes will include measures of ED care, subsequent healthcare utilization, substance use treatment, overdose, mortality, and other relevant clinical and health-service outcomes.

Investigators will request routinely collected records for Vancouver General Hospital ED visits during the study period. Records of eligible ED patients presenting during the study period will be linked to provincial administrative data to evaluate outcomes. Data sources will include the National Ambulatory Care Reporting System (NACRS), Discharge Abstract Database (DAD), Vital Statistics, PharmaNet, Medical Services Plan (MSP), and the Central Demographics File. Population Data BC and Health Data Platform BC will support secure data linkage, and additional relevant datasets may be explored where useful to the study objectives.

These data will support cohort definition, construction of comparison groups, development of propensity scores, sensitivity analyses, and evaluation of outcomes including receipt of ED treatments and referrals, ED revisits, hospitalizations, overdose, opioid agonist therapies and other addiction treatments, mortality, and other relevant health-service outcomes.

Investigators will also obtain records of security-related events occurring during ED visits over the study period. These data will be used to examine whether Peer availability is associated with differences in events such as need for de-escalation or other security involvement.

Tipo de estudo

Intervencional

Inscrição (Estimado)

3781

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Elle Wang, MSc
  • Número de telefone: 604-615-2538
  • E-mail: elle.wang@ubc.ca

Estude backup de contato

Locais de estudo

    • British Columbia
      • Vancouver, British Columbia, Canadá, V5Z 1M9
        • Recrutamento
        • Vancouver General Hospital
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Emergency Department (ED) patient at Vancouver General Hospital (VGH)
  • Age 18 years or older
  • Identified as using substances
  • Able to receive or decline peer support services during the ED visit

Exclusion Criteria:

  • Under 18 years of age
  • Does not report substance use

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Peer Support Intervention

Investigators will evaluate the Peer Support intervention using two analytical approaches:

  1. Primary Analysis (Intention-to-Treat): Peer Available Shift Patients who presented to the emergency department (ED) with substance use-related complaints during shifts when a Peer support worker was scheduled to be available, according to an a priori randomized schedule. Patients may or may not have directly interacted with a Peer during their ED visit. All eligible patients will be analyzed according to their randomized shift assignment, regardless of whether a direct Peer-patient interaction occurred.
  2. Secondary Analysis: Interacted With Peer Patients who presented to the ED with substance use-related concerns and directly interacted with a Peer support worker during their ED visit. Peer activities may have included harm reduction support, provision of naloxone and sterile drug use supplies, linkage to substance use treatment, and connections to follow-up care and community resources.

During intervention shifts, Peer support workers were scheduled to be available in the emergency department to provide support to patients with substance use-related concerns. Peer support workers offered services tailored to individual patients' needs, including referrals to clinical and social support services (e.g., social work, addictions specialists, Indigenous patient navigators, and community-based addiction services), provision of resources (e.g., blankets, food, naloxone kits, sterile drug use supplies, and information brochures), emotional support, and communication support between patients and healthcare providers regarding patients' conditions and ED care. The primary analysis will evaluate the effect of randomized Peer availability using an intention-to-treat approach. The secondary analysis will evaluate outcomes associated with actual Peer-patient interactions by comparing patients who received Peer support with comparable patients who did not.

Sem intervenção: No Peer Support Intervention

Investigators will define the comparison group using two approaches:

  1. Primary Analysis (Intention-to-Treat): No Peer Available Shift Patients presenting to the ED with substance use-related complaints during shifts randomized to no Peer availability.
  2. Secondary Analysis: Did Not Interact With Peer Patients presenting with similar substance use-related complaints who did not directly interact with a Peer. Investigators will use propensity score weighting to improve comparability with patients who received Peer support. The model will include relevant covariates (e.g., age, sex, area-level deprivation, prior substance use-related ED visits and hospitalizations, and prescriptions for substance dependence medications recorded in PharmaNet during the previous 12 months).

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Leaving Before Treatment Completion (LBTC)
Prazo: From enrollment through 12 months of follow-up

Investigators will measure LBTC among ED patients with substance use-related complaints (e.g., substance withdrawal, misuse/intoxication, overdose, and localized swelling/redness).

Investigators will evaluate LBTC using two approaches:

  1. Primary Analysis (Intention-to-Treat): Peer vs. No Peer Shifts Investigators will classify eligible ED visits based on the randomized Peer schedule. For each shift, investigators will calculate the percentage of eligible visits resulting in LBTC. Linear regression will be used to compare LBTC percentages between Peer and No Peer shifts, regardless of actual Peer interaction.
  2. Secondary Analysis: Peer Interaction vs. No Peer Interaction Investigators will use propensity score weighting to improve comparability between patients who interacted with a Peer and those who did not. Mixed-effects logistic regression will be used to compare LBTC probabilities between groups, accounting for clustering by shift and adjusting for relevant covariates.
From enrollment through 12 months of follow-up

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Distribution of randomized Peer shifts by day of week (feasibility outcome)
Prazo: From study initiation to achievement of full Peer staffing, approximately one year

Assessed by examining the distribution of scheduled Peer shifts across each day of the week over the 48-week randomized schedule period. The schedule was developed in collaboration with human resources and ED operational leadership and approved as meeting hospital employee policy. The randomization approach used block-based scheduling with built-in constraints (e.g., mandatory weekends off). This outcome evaluates whether the resulting schedule achieved a balanced weekday/weekend distribution.

Unit of Measure: Number and percentage of Peer shifts scheduled per day of the week

From study initiation to achievement of full Peer staffing, approximately one year
ED-based substance use and harm reduction interventions
Prazo: Baseline

Secondary outcomes will include receipt of naloxone kits, opioid agonist therapy doses, and withdrawal treatments during the ED visit. Investigators will compare counts of these outcomes between intervention (Peer) and control (no Peer) groups using multivariable count regression. Investigators will assess clustering of outcomes by shift and adjust for the same covariates included in the primary analysis.

Baseline
30-day health care utilization and clinical events (e.g., drug poisoning, mortality)
Prazo: From enrollment through 30 days of follow-up from ED visit

Exploratory outcomes will include ED visits, hospitalizations, drug poisoning, and mortality within 30 days following the index ED visit. Investigators will analyze counts of these events using multivariable count regression, with the log-transformed length of follow-up included as an offset term where applicable, and will conduct time-to-event analyses using Cox regression. Investigators will assess clustering of outcomes by shift and adjust for the same covariates included in the primary analysis.

From enrollment through 30 days of follow-up from ED visit
Security-related events during ED visits
Prazo: Baseline

Investigators will obtain records of security-related events occurring during ED visits over the study period from the ED security event database. Investigators will assess whether Peer availability was associated with differences in the frequency and type of security-related events, including escalation events and incidents requiring security involvement.

Baseline
Thematic summary of Indigenous patients' experiences with the Peer program
Prazo: Within 6 months after the patient's ED visit involving Peer interaction

Indigenous patient perspectives on the Peer program will be collected through surveys, culturally grounded storytelling and sharing circles. Sessions will be guided by open-ended questions to explore perceived safety, support, and emotional impact of Peer involvement in the emergency department. Transcripts will be analyzed using Indigenous-informed thematic analysis to identify key insights and priorities for culturally safe care.

Unit of Measure: Themes and narratives identified through qualitative analysis

Within 6 months after the patient's ED visit involving Peer interaction
Thematic summary of healthcare providers' perceptions of the Peer program assessed through focus groups
Prazo: From 12-24 months after Peer program implementation

Acceptability of the Peer program among healthcare providers will be evaluated using semi-structured focus groups conducted periodically post-implementation. Discussions will explore perceived value, observed patient impact, integration into ED workflows, challenges, and suggestions for improvement. Audio recordings will be transcribed and analyzed using thematic content analysis to identify recurring patterns and representative quotes.

Unit of Measure: Thematic categories identified through qualitative analysis

From 12-24 months after Peer program implementation
Thematic summary of PWLLE perceptions and experiences of the Peer program assessed through focus groups
Prazo: From 12-24 months after Peer program implementation

Perspectives of people with lived and living experience (PWLLE) on the Peer program will be evaluated using semi-structured focus groups. Discussions will explore participants' perceptions of the value and accessibility of Peer support, experiences of substance use-related care in the ED, perceived impacts of the Peer program, barriers and gaps in care, and suggestions for improving Peer support and program delivery. Audio recordings will be transcribed and analyzed using thematic content analysis to identify recurring themes and representative quotes. Unit of Measure: Thematic categories identified through qualitative analysis

From 12-24 months after Peer program implementation
Acceptability of the Peer program evaluated through periodic surveys
Prazo: From 12-24 months after Peer program implementation

Acceptability and implementation of the Peer program will be assessed through periodic surveys administered to Peers, patients accessing Peer services, members of the ED buprenorphine/naloxone team, and multidisciplinary healthcare providers. Surveys will assess experiences with the Peer program, including perceived value, respect, ease of communication, clarity of information, comfort, confidentiality, teamwork, integration into ED workflows, and perceived facilitators and barriers to implementation.

From 12-24 months after Peer program implementation

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Jessica Moe, MD, University of British Columbia

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

23 de novembro de 2024

Conclusão Primária (Estimado)

1 de março de 2028

Conclusão do estudo (Estimado)

1 de dezembro de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

3 de junho de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

11 de junho de 2025

Primeira postagem (Real)

22 de junho de 2025

Atualizações de registro de estudo

Última Atualização Postada (Real)

3 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

29 de outubro de 2026

Última verificação

1 de outubro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • H24-03008
  • F26-03530 (Número de outro subsídio/financiamento: Health Canada)
  • F25-02658 (Número de outro subsídio/financiamento: Vancouver Coastal Health Research Institute)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

There is no plan to make individual participant data available to other researchers

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever